Last updated 2026-07-26
- Raised $11M Series E led by Israel Biotech Fund, Sep 2024
- Raised $16M Series C led by Israel Biotech Fund, Oct 2021
- Raised $3M Series D led by Merz Therapeutics, Jan 2022
Total raised
$33.2M
Last: Undisclosed Round 2024-10
Stage
Seed
Founded
2014
Headcount
13
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
Vensica Medical is a clinical-stage biotechnology company developing needle-free therapeutic delivery solutions for urologic diseases. The company's proprietary Vibe® platform uses focused ultrasound to enable localized delivery of biologic and small-molecule drugs into the bladder wall. Vensica's lead program, ViXe, combines the Vibe system with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). Vensica's technology aims to provide a minimally invasive, more comfortable, and effective treatment option compared to traditional injections.
Funding history · 6 rounds · $33.2M total
2024-09
E Round
$11.0M
★ Israel Biotech Fund
2022-01
D Round
$3.0M
★ Merz Therapeutics
2021-10
C Round
$16.0M
★ Israel Biotech FundAgrilineLewis PellLaborie Medical Technologies
2017-08
B Round
$2.0M
★ Cogentix MedicalAccelmed
2016-06
A Round
$500K
2014-07
Seed
$700K
Headcount over time
From 3 (2018-09) to 5 (2026-07) · +2 (+67%) · 19 points · source: Finder history + radar grounding
Q&A
- What is Vensica Medical's primary focus?
- Vensica Medical is a clinical-stage biotechnology company that develops needle-free therapeutic delivery solutions for urologic diseases, utilizing its proprietary Vibe® platform for localized drug delivery into the bladder wall.
- When was Vensica Medical founded?
- Vensica Medical was founded in 2014.
- How many employees does Vensica Medical currently have?
- Vensica Medical has 11-50 employees.
- What was Vensica Medical's most recent funding round?
- Key investors included Israel Biotech Fund (IBF), Merz, and Laborie.
- Which investors participated in Vensica Medical's B Round in November 2021?
- The B Round in November 2021 included investments from Israel Biotech Fund (IBF) and Laborie.
- What is Vensica Medical's lead product program?
- Vensica Medical's lead program, ViXe, combines the Vibe system with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB).
- What was the amount raised in Vensica Medical's B Round in February 2022?
- In February 2022, Vensica Medical raised $20,000,000 in a B Round, with.
- What is the core technology behind Vensica Medical's drug delivery system?
- Vensica Medical's Vibe® platform uses focused ultrasound to enable localized delivery of biologic and small-molecule drugs into the bladder wall.
Team · 2
Avner Geva
Founder · Founder & CEO
Avi Eftel
Founder · CTO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
hospitalscancerdrug-deliverymedical-devicesurinary-systemcathetersultrasoundoncologyurologyminimally-invasivepain-freetreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | vensica.com |
|---|---|
| linkedin.com/company/5350087 | |
| YouTube | youtube.com/@VensicaMedical |
Identifiers & details
| Founded | 2014 |
|---|---|
| Employees (exact) | 13 |
| Offices | New York |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | vensica.com |
|---|
Certificate / subdomain footprint
| Subdomains | 5 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515110765 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-07-20 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — violation (1), annual_report (2), people (1), shares_capital (1) |
| Registered address | הגביש 4 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-12 | עדכון הפרה |
| 2026-04-12 | דו~ח שנתי-הקצאת מניות |
| 2026-04-12 | דו~ח שנתי-הסרת דירקטור |
| 2026-04-06 | עדכון בעלי תפקידים |
| 2026-04-05 | הגדלה של הון רשום |